26 February 2026 THEME 1 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS This document contains statements that are, or may be deemed to be, "forward-looking statements". Forward- looking statements give the Company's current expectations or forecasts of future events. These forward-looking statements may include, among other things, plans, objectives, beliefs, intentions, strategies, projections and anticipated future economic performance based on assumptions and the like that are subject to risk ...

Unlocking the next level Capital Markets Day 2026 Programme 09:00 PRESENTATIONS Unlocking the next level Technology as a strategic enabler of operational excellence Johan Rostoft, EVP Technology and Insight Positioning for growth and enhanced efficiency René Fløystøl, EVP Private Shaping the next level Lars Gøran Bjerklund, EVP Commercial 10:40 PRESENTATIONS Driving the next level of claims excellence Vivi Kofoed, EVP Claims Delivering attractive returns Jostein Amdal, CFO 11:20 Q&A SESSION 10:20 BREAK ~12: ...

Presentations Page (IR website) FY2025 Analysts Briefing 1 Financial Highlights Stable expansion reflected in record service revenues and EBITDA; Maya gains supported core uptick | | FY25 | FY24 | Change | % Change | | --- | --- | --- | --- | --- | | Service Revenues [net of interconnection costs] | 196.2bn | 194.7bn | +1.5bn | +1% | | Cash Opex, Subsidies, Provisions (ex-MRP) | 84.9bn | 86.1bn | -1.2bn | -1% | | EBITDA (ex-MRP) | 111.2bn 52% margin | 108.5bn 52% margin | +2.7bn | +3% | | Depreciation & Amo ...

Leasing Business Deep Dive Update FY 2025 February 2026 Frankfurt Disclaimer This document has been prepared by KION GROUP AG (the "Company", and together with its consolidated subsidiaries, the "KION Group") solely for informational purposes. This disclaimer shall apply in all respects to the entire presentation (including all slides of this document), the oral presen- tation of the slides by representatives of the Company (or any person on behalf of the Company), any question-and-answer session that follo ...

Navigating adverse economic climate Roadshow presentation covestro.com FY 2025 │ IR Roadshow Presentation 0 Covestro investment highlights FY 2025 │ IR Roadshow Presentation 1 Covestro is diversified across geographies and end-markets Key performance indicators and sales split 51% 47% 18% 18% 14% 14% 6% 31% Performance Materials Solutions & Specialties Sports / leisure, cosmetics, health, diverse industries Chemicals Electrical, electronics & Construction Furniture & wood Automotive & transportation 2025 sa ...

Investor company presentation February 2026 Forward-looking statements The information in this presentation contains certain "forward-looking statements", relating to the company's business, which can be identified by the use of forward-looking terminology such as "intend", "estimates", "believes", "expects", "may", "are expected to", "will", "will continue", "should", "would be", "seeks", "pending" or "anticipates" or similar expressions, or by discussions of strategy, plans or intentions. Such statements ...

Sustainability Meeting 2025 Astellas Pharma Inc. February 26, 2026 ことを確認してください。 ©2026 ASTELLAS PHARMA INC. AND ITS AFFILIATES. アステラス 製薬の画像は、 MediaValetから入手で きます(ガイダンススラ イドを参照)。 スライドマスターファイ ルに機密保持または著作 権表示 に関する正しい フッターを追加している Cautionary Statement Regarding Forward-Looking Information In this material, statements made with respect to current plans, estimates, strategies and beliefs and other statements that are not historical facts are forward-looking statements about the future performance of Astellas Pharma ...

Q4 & FY 2025 EARNINGS PRESENTATION FEBRUARY 25, 2026 1 DISCLAIMER – FORWARD LOOKING STATEMENTS & NON-GAAP DISCLOSURE This presentation contains forward-looking statements that involve substantial risks and uncertainties. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and Section 27A of the Securities Act of 1933, as amended (the "Securities A ...

Earnings Presentation Fourth Quarter and Full Year 2025 February 25, 2026 CBIZ.COM | NYSE: CBZ Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements other than statements of historical fact included in this presentation, including, without limitation our "2026 Outlook," regardin ...

NASDAQ: MRVI Q4 and Year-end 2025 Financial Results February 25, 2026 Agenda | 01 | Welcome | Deb Hart, Head of Investor Relations | | --- | --- | --- | | 02 | Business Highlights | Bernd Brust, Chief Executive Officer | | 03 | Financial Results | Raj Asarpota, Chief Financial Officer | | | & Guidance | | | 04 | Q&A Session | Bernd Brust, Chief Executive Officer | | | | Raj Asarpota, Chief Financial Officer | | | | Chanfeng Zhao, Chief Scientific Officer | ©2026 Maravai LifeSciences. This document and its c ...